From: Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case
Day 1
Day 5
Physical
10.6
10.7
Emotional
4.1
4.0
Social
3.0
Fatigue
12.2
11.8
Pain
1.0
Dyspnea
2.1
2.2
Global quality of life
9.0
9.1